Michael Ramcharan

Managing Director - Reumat Consulting

Michael Ramcharan (Reumat Consulting Ltd) has over 30 years of experience in Quality Assurance having worked with multinational Pharmaceutical and Clinical Research Organisations (CRO) mainly in the GCP and GPV areas. He has conducted a wide variety of audits (both On-site and Remote) globally, and managed various risk-based audit programmes. He has also hosted and supported many European Regulatory Authority Inspections (eg; MHRA, EMA, Local EU country Inspectorates). Michael’s audit experience has also extended to designing and implementing various audit and Training programmes, providing Training on a variety of GCP and GPV topics, and for providing general Quality Management System (QMS) support. He is currently a member of Research Quality Assurance (RQA), and an active committee member of the RQA Wales & South-West, UK Regional group, and member of the RQA Special Interest Group (SIG) on Non-Interventional Real World Data/Real World Evidence Studies, and RQA SIG Consultants Group.


See more at: www.reumatconsulting.co.uk

Michael Ramcharan


  • Tuesday - November 22, 2022 - 11:10

    Panel Discussion - An Integrated care: Effective Implementation of vigilances systems

    • Separated vigilance systems can lead to the emergence of divergence in terms, definitions, variety of reporting forms and methods and the build of specific databases where cross analysis is no more possible.
    • To be more proactive and innovative in PV and to ensure that emerging problems are promptly recognized and solutions are effectively communicated
    • This integrated approach is very useful, especially for emerging countries to strengthen regulatory processes and to promote high standards of product vigilance for the protection of the health and safety of Citizens

      Watch Session

  • Tuesday - November 22, 2022 - 13:40

    Fireside Chat - REMS Compliance and Inspection Readiness

      Watch Session

  • Wednesday - November 23, 2022 - 14:25

    Panel Discussion – The future of pharmacovigilance: How technology will change the way we monitor drugs

    • The future of pharmacovigilance will be more automated
    • AI will play a big role in data management and analysis
    • The use of technology will increase speed and accuracy

      Watch Session

  • Wednesday - November 23, 2022 - 17:50

    Chairperson’s closing remarks & End of Conference

      Watch Session


Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now